Molina Healthcare (NYSE:MOH) Downgraded by StockNews.com to “Hold”

Molina Healthcare (NYSE:MOH) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday.

A number of other brokerages have also recently weighed in on MOH. Robert W. Baird initiated coverage on Molina Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $405.00 price target on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Molina Healthcare from $354.00 to $353.00 and set a “hold” rating for the company in a research report on Monday, July 29th. Truist Financial reduced their price target on shares of Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. Stephens reiterated an “equal weight” rating and issued a $320.00 target price on shares of Molina Healthcare in a research note on Thursday, July 25th. Finally, Jefferies Financial Group reduced their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating on the stock in a report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $378.00.

Molina Healthcare Price Performance

Shares of MOH stock traded up $2.10 during mid-day trading on Wednesday, reaching $355.15. The company’s stock had a trading volume of 331,969 shares, compared to its average volume of 496,623. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. The firm’s 50-day moving average is $333.24 and its two-hundred day moving average is $343.64. Molina Healthcare has a 1-year low of $282.96 and a 1-year high of $423.92. The company has a market cap of $20.81 billion, a P/E ratio of 19.27, a PEG ratio of 1.20 and a beta of 0.57.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, July 24th. The company reported $5.86 EPS for the quarter, topping analysts’ consensus estimates of $5.73 by $0.13. Molina Healthcare had a net margin of 2.84% and a return on equity of 28.09%. The firm had revenue of $9.88 billion during the quarter, compared to analysts’ expectations of $9.75 billion. During the same quarter last year, the company earned $5.65 earnings per share. The company’s revenue for the quarter was up 18.7% compared to the same quarter last year. On average, research analysts predict that Molina Healthcare will post 23.5 earnings per share for the current year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now directly owns 18,025 shares in the company, valued at approximately $6,114,260.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 393 shares of Molina Healthcare stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Hedge Funds Weigh In On Molina Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MOH. Sanctuary Advisors LLC acquired a new position in shares of Molina Healthcare in the 2nd quarter valued at $1,077,000. Aurora Investment Counsel bought a new position in Molina Healthcare during the second quarter worth about $1,859,000. Quarry LP acquired a new position in Molina Healthcare in the second quarter valued at about $171,000. Algert Global LLC bought a new stake in shares of Molina Healthcare in the second quarter worth about $211,000. Finally, Scientech Research LLC bought a new stake in shares of Molina Healthcare in the second quarter worth about $2,448,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.